Page last updated: 2024-10-18

glycine and Thyroid Carcinoma, Anaplastic

glycine has been researched along with Thyroid Carcinoma, Anaplastic in 2 studies

Thyroid Carcinoma, Anaplastic: An aggressive THYROID GLAND malignancy which generally occurs in IODINE-deficient areas in people with previous thyroid pathology such as GOITER. It is associated with CELL DEDIFFERENTIATION of THYROID CARCINOMA (e.g., FOLLICULAR THYROID CARCINOMA; PAPILLARY THYROID CANCER). Typical initial presentation is a rapidly growing neck mass which upon metastasis is associated with DYSPHAGIA; NECK PAIN; bone pain; DYSPNEA; and NEUROLOGIC DEFICITS.

Research Excerpts

ExcerptRelevanceReference
"Anaplastic thyroid cancer (ATC) is one of the most aggressive and lethal tumor types, characterized by loss of differentiation, epithelial-to-mesenchymal transition, extremely high proliferation rate, and generalized resistance to therapy."1.91Anaplastic thyroid cancer cells upregulate mitochondrial one-carbon metabolism to meet purine demand, eliciting a critical targetable vulnerability. ( Di Cristofano, A; Huynh, LD; Shabro, A; Sugarman, AJ, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sugarman, AJ1
Huynh, LD1
Shabro, A1
Di Cristofano, A1
Kim, SH1
Kang, JG1
Kim, CS1
Ihm, SH1
Choi, MG1
Yoo, HJ1
Lee, SJ1

Other Studies

2 other studies available for glycine and Thyroid Carcinoma, Anaplastic

ArticleYear
Anaplastic thyroid cancer cells upregulate mitochondrial one-carbon metabolism to meet purine demand, eliciting a critical targetable vulnerability.
    Cancer letters, 2023, 08-01, Volume: 568

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Glycine; Humans; Mice; Purines; Thyroid Carcinoma, An

2023
The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells.
    Endocrine, 2016, Volume: 51, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; Caspase 3; Cell Line, Tumor; Cell Survival; Drug Syner

2016